Bassat Orellana, QuiqueMenéndez, Clara2016-12-092016-12-092016-11-161473-3099https://hdl.handle.net/2445/104547Historically, antimalarial drugs have been used at a population level in malaria-endemic areas with the objective of decreasing the burden, impact, and transmissibility of malaria.1 Continuous chemoprophylaxis, once experimented but never seriously considered a feasible wide-scale implementable strategy, has been superseded by the concept of intermittent treatment targeting different population groups, presenting many advantages, including non-interference with the acquisition of natural immunity against malaria.2 p.application/pdfengcc by (c) Bassat et al., 2016http://creativecommons.org/licenses/by/4.0/MalàriaAdministració de medicamentsMalariaAdministration of drugsDihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?info:eu-repo/semantics/article2016-11-30info:eu-repo/semantics/openAccess